{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:16:22Z","timestamp":1784715382651,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2628-B-002-055"],"award-info":[{"award-number":["110-2628-B-002-055"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110050","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T06:16:18Z","timestamp":1661580978000},"page":"110050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus"],"prefix":"10.1016","volume":"191","author":[{"given":"Tsung-Yu","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Tse","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Chi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lwun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9529","key":"10.1016\/j.diabres.2022.110050_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","article-title":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study","volume":"368","author":"Booth","year":"2006","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.diabres.2022.110050_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.diabres.2022.110050_b0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9540","key":"10.1016\/j.diabres.2022.110050_b0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diabres.2022.110050_b0025","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1378\/chest.113.4.1109","article-title":"The natural history and rate of progression of aortic stenosis","volume":"113","author":"Lester","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.diabres.2022.110050_b0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","article-title":"Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes","volume":"19","author":"Kopytek","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2022.110050_b0035","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","article-title":"Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study","volume":"69","author":"Yan","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110050_b0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10753-011-9384-7","article-title":"Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?","volume":"35","author":"Natorska","year":"2012","journal-title":"Inflammation"},{"issue":"17","key":"10.1016\/j.diabres.2022.110050_b0045","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","article-title":"Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis","volume":"113","author":"Katz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110050_b0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2017.06.104","article-title":"Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis","volume":"244","author":"Testuz","year":"2017","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.diabres.2022.110050_b0055","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jfma.2021.12.024","article-title":"Quality assurance of integrative big data for medical research within a multihospital system","volume":"121","author":"Lee","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.diabres.2022.110050_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2015.96","article-title":"Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis","volume":"88","author":"Lin","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2022.110050_b0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-021-01341-3","article-title":"Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus","volume":"20","author":"Hsu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2022.110050_b0070","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.diabres.2022.110050_b0080","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110050_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/cvr\/cvaa064","article-title":"Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress","volume":"117","author":"Packer","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.diabres.2022.110050_b0090","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0735-1097(94)90606-8","article-title":"Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves","volume":"23","author":"Olsson","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2022.110050_b0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2012.01.019","article-title":"Advanced glycation end-product N\u03b5-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes","volume":"221","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2022.110050_b0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2022.110050_b0105","doi-asserted-by":"crossref","unstructured":"Roderburg C, Loosen SH, Luedde T, Kostev K, Luedde M. Diabetes mellitus is associated with an increased incidence of aortic valve stenosis. Diab Vasc Dis Res. 2021;18:14791641211033819.","DOI":"10.1177\/14791641211033819"},{"issue":"10","key":"10.1016\/j.diabres.2022.110050_b0110","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.diabres.2022.110050_b0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.diabres.2022.110050_b0120","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2022.110050_b0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2022.110050_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.diabres.2022.110050_b0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.diabres.2022.110050_b0140","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:44:33Z","timestamp":1778730273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":27,"alternative-id":["S0168822722008646"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110050","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110050"}}